{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:04:10Z","timestamp":1779167050106,"version":"3.51.4"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03815-2","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:50:33Z","timestamp":1761299433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The potential of luteolin-conjugated mesoporous silica nanoparticles functionalized with folic acid in targeted cancer therapy in an in vitro model"],"prefix":"10.1007","volume":"16","author":[{"given":"Maryam","family":"Hosseini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Homayouni Tabrizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bita","family":"Behboodian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mozhgan","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"issue":"10","key":"3815_CR1","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1007\/s11427-024-2657-y","volume":"67","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zheng Z. Understanding the global cancer statistics 2022: growing cancer burden. Sci China Life Sci. 2024;67(10):2274\u20136.","journal-title":"Sci China Life Sci"},{"key":"3815_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2024.135319","volume":"477","author":"J Chen","year":"2024","unstructured":"Chen J, Cui Y, Deng Y, Xiang Y, Chen J, Wang Y, et al. Global, regional, and national burden of cancers attributable to particulate matter pollution from 1990 to 2019 and projection to 2050: worsening or improving? J Hazard Mater. 2024;477:135319.","journal-title":"J Hazard Mater"},{"issue":"7","key":"3815_CR3","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2174\/156800908786241050","volume":"8","author":"Y Lin","year":"2008","unstructured":"Lin Y, Shi R, Wang X, Shen H-M. Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets. 2008;8(7):634\u201346.","journal-title":"Curr Cancer Drug Targets"},{"key":"3815_CR4","doi-asserted-by":"crossref","unstructured":"Tewari D, Patni P, Bishayee A, Sah AN, Bishayee A, editors. Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: a novel therapeutic strategy. Semin Cancer Biol. 2022.","DOI":"10.1016\/j.semcancer.2019.12.008"},{"issue":"5","key":"3815_CR5","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s43440-020-00138-7","volume":"72","author":"T Haider","year":"2020","unstructured":"Haider T, Pandey V, Banjare N, Gupta PN, Soni V. Drug resistance in cancer: mechanisms and tackling strategies. Pharmacol Rep. 2020;72(5):1125\u201351.","journal-title":"Pharmacol Rep"},{"key":"3815_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2022.102746","volume":"307","author":"GC Carvalho","year":"2022","unstructured":"Carvalho GC, Marena GD, Karnopp JCF, Jorge J, S\u00e1bio RM, Martines MAU, et al. Cetyltrimethylammonium bromide in the synthesis of mesoporous silica nanoparticles: general aspects and in vitro toxicity. Adv Colloid Interface Sci. 2022;307:102746.","journal-title":"Adv Colloid Interface Sci"},{"key":"3815_CR7","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1016\/j.ijbiomac.2020.08.091","volume":"164","author":"RD Gupta","year":"2020","unstructured":"Gupta RD, Raghav N. Differential effect of surfactants tetra-n-butyl ammonium bromide and N-cetyl-N, N, N-trimethyl ammonium bromide bound to nano-cellulose on binding and sustained release of some non-steroidal anti-inflammatory drugs. Int J Biol Macromol. 2020;164:2745\u201352.","journal-title":"Int J Biol Macromol"},{"key":"3815_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.surfin.2021.101565","volume":"27","author":"APF Monteiro","year":"2021","unstructured":"Monteiro APF, Idczak G, Tilkin RG, Vandeberg RM, Vertruyen B, Lambert SD, et al. Evaluation of hydroxyapatite texture using CTAB template and effects on protein adsorption. Surf Interface. 2021;27:101565.","journal-title":"Surf Interface"},{"issue":"11","key":"3815_CR9","volume":"8","author":"RA Shende","year":"2023","unstructured":"Shende RA, Chaudhari BP. Robust optimization and characterization of MCM-41 nanoparticle synthesis using modified sol-gel method. ChemSelect. 2023;8(11):e202204968.","journal-title":"ChemSelect"},{"key":"3815_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108612","volume":"112","author":"M Imran","year":"2019","unstructured":"Imran M, Rauf A, Abu-Izneid T, Nadeem M, Shariati MA, Khan IA, et al. Luteolin, a flavonoid, as an anticancer agent: a review. Biomed Pharmacother. 2019;112:108612.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"3815_CR11","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.3892\/ol.2017.6380","volume":"14","author":"X Lu","year":"2017","unstructured":"Lu X, Li Y, Li X, Aisa HA. Luteolin induces apoptosis in vitro through suppressing the MAPK and PI3K signaling pathways in gastric cancer. Oncol Lett. 2017;14(2):1993\u20132000.","journal-title":"Oncol Lett"},{"issue":"3","key":"3815_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2021.12452","volume":"21","author":"R Raina","year":"2021","unstructured":"Raina R, Pramodh S, Rais N, Haque S, Shafarin J, Bajbouj K, et al. Luteolin inhibits proliferation, triggers apoptosis and modulates Akt\/mTOR and MAP kinase pathways in HeLa cells. Oncol Lett. 2021;21(3):1.","journal-title":"Oncol Lett"},{"issue":"2","key":"3815_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cbi.2006.01.002","volume":"160","author":"W-J Lee","year":"2006","unstructured":"Lee W-J, Wu L-F, Chen W-K, Wang C-J, Tseng T-H. Inhibitory effect of Luteolin on hepatocyte growth factor\/scatter factor-induced HepG2 cell invasion involving both MAPK\/ERKs and PI3K\u2013Akt pathways. Chemico-Biological Interactions. 2006;160(2):123\u201333.","journal-title":"Chemico-Biological Interactions"},{"issue":"4","key":"3815_CR14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/biom10040502","volume":"10","author":"BK Velmurugan","year":"2020","unstructured":"Velmurugan BK, Lin J-T, Mahalakshmi B, Chuang Y-C, Lin C-C, Lo Y-S, et al. Luteolin-7-O-glucoside inhibits oral cancer cell migration and invasion by regulating matrix metalloproteinase-2 expression and extracellular signal-regulated kinase pathway. Biomolecules. 2020;10(4):502.","journal-title":"Biomolecules"},{"issue":"1","key":"3815_CR15","doi-asserted-by":"publisher","first-page":"11949","DOI":"10.1038\/s41598-022-16220-4","volume":"12","author":"A Miyashita","year":"2022","unstructured":"Miyashita A, Ito J, Parida IS, Syoji N, Fujii T, Takahashi H, et al. Improving water dispersibility and bioavailability of Luteolin using microemulsion system. Sci Rep. 2022;12(1):11949.","journal-title":"Sci Rep"},{"key":"3815_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.biomaterials.2016.10.016","volume":"112","author":"S-Y Qin","year":"2017","unstructured":"Qin S-Y, Zhang A-Q, Cheng S-X, Rong L, Zhang X-Z. Drug self-delivery systems for cancer therapy. Biomaterials. 2017;112:234\u201347.","journal-title":"Biomaterials"},{"issue":"3","key":"3815_CR17","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1021\/acsabm.2c00002","volume":"5","author":"MI Khan","year":"2022","unstructured":"Khan MI, Hossain MI, Hossain MK, Rubel M, Hossain K, Mahfuz A, et al. Recent progress in nanostructured smart drug delivery systems for cancer therapy: a review. ACS Appl Bio Mater. 2022;5(3):971\u20131012.","journal-title":"ACS Appl Bio Mater"},{"key":"3815_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.smaim.2020.04.001","volume":"1","author":"Y Dang","year":"2020","unstructured":"Dang Y, Guan J. Nanoparticle-based drug delivery systems for cancer therapy. Smart Materials in Medicine. 2020;1:10\u20139.","journal-title":"Smart Materials in Medicine"},{"key":"3815_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/15330338231152083","volume":"22","author":"U Dristant","year":"2023","unstructured":"Dristant U, Mukherjee K, Saha S, Maity D. An overview of polymeric nanoparticles-based drug delivery system in cancer treatment. Technol Cancer Res Treat. 2023;22:15330338231152083.","journal-title":"Technol Cancer Res Treat"},{"issue":"4","key":"3815_CR20","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/pharmaceutics12040298","volume":"12","author":"N Avramovi\u0107","year":"2020","unstructured":"Avramovi\u0107 N, Mandi\u0107 B, Savi\u0107-Radojevi\u0107 A, Simi\u0107 T. Polymeric nanocarriers of drug delivery systems in cancer therapy. Pharmaceutics. 2020;12(4):298.","journal-title":"Pharmaceutics"},{"key":"3815_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2019.02.031","volume":"89","author":"T Li","year":"2019","unstructured":"Li T, Shi S, Goel S, Shen X, Xie X, Chen Z, et al. Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer. Acta Biomater. 2019;89:1\u201313.","journal-title":"Acta Biomater"},{"key":"3815_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ccr.2016.04.019","volume":"319","author":"Y Feng","year":"2016","unstructured":"Feng Y, Panwar N, Tng DJH, Tjin SC, Wang K, Yong K-T. The application of mesoporous silica nanoparticle family in cancer theranostics. Coord Chem Rev. 2016;319:86\u2013109.","journal-title":"Coord Chem Rev"},{"key":"3815_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2021.115417","volume":"328","author":"AS Taleghani","year":"2021","unstructured":"Taleghani AS, Nakhjiri AT, Khakzad MJ, Rezayat SM, Ebrahimnejad P, Heydarinasab A, et al. Mesoporous silica nanoparticles as a versatile nanocarrier for cancer treatment: a review. J Mol Liq. 2021;328:115417.","journal-title":"J Mol Liq"},{"issue":"39","key":"3815_CR24","doi-asserted-by":"publisher","first-page":"23148","DOI":"10.1039\/D0RA00664E","volume":"10","author":"S Mishra","year":"2020","unstructured":"Mishra S, Manna K, Kayal U, Saha M, Chatterjee S, Chandra D, et al. Folic acid-conjugated magnetic mesoporous silica nanoparticles loaded with quercetin: a theranostic approach for cancer management. RSC Adv. 2020;10(39):23148\u201364.","journal-title":"RSC Adv"},{"key":"3815_CR25","doi-asserted-by":"publisher","unstructured":"Frigerio B, Bizzoni C, Jansen G, Leamon CP, Peters GJ, Low PS, et al. Folate receptors and transporters: biological role and diagnostic\/therapeutic targets in cancer and other diseases. J Exp Clin Cancer Res. 2019. https:\/\/doi.org\/10.1186\/s13046-019-1123-1.","DOI":"10.1186\/s13046-019-1123-1"},{"key":"3815_CR26","doi-asserted-by":"publisher","first-page":"7315","DOI":"10.2147\/OTT.S113815","volume":"9","author":"P Khosravian","year":"2016","unstructured":"Khosravian P, Shafiee Ardestani M, Khoobi M, Ostad SN, Dorkoosh FA, Akbari Javar H, et al. Mesoporous silica nanoparticles functionalized with folic acid\/methionine for active targeted delivery of docetaxel. Onco Targets Ther. 2016;9:7315\u201330.","journal-title":"Onco Targets Ther"},{"issue":"31","key":"3815_CR27","doi-asserted-by":"publisher","first-page":"21365","DOI":"10.1039\/D3RA02969G","volume":"13","author":"L Hong","year":"2023","unstructured":"Hong L, Li W, Li Y, Yin S. Nanoparticle-based drug delivery systems targeting cancer cell surfaces. RSC Adv. 2023;13(31):21365\u201382.","journal-title":"RSC Adv"},{"issue":"32","key":"3815_CR28","doi-asserted-by":"publisher","first-page":"22250","DOI":"10.1039\/D3RA02772D","volume":"13","author":"M Iranshahy","year":"2023","unstructured":"Iranshahy M, Hanafi-Bojd MY, Aghili SH, Iranshahi M, Nabavi SM, Saberi S, et al. Curcumin-loaded mesoporous silica nanoparticles for drug delivery: synthesis, biological assays and therapeutic potential \u2013 a review. RSC Adv. 2023;13(32):22250\u201367.","journal-title":"RSC Adv"},{"issue":"2","key":"3815_CR29","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00210-024-03325-y","volume":"398","author":"S Nosrati","year":"2025","unstructured":"Nosrati S, Javid H, Amiri H, Jafari N, Hashemy SI. Investigating the anticancer effects of chitosan-NLC-folate nanohybrid loaded with auraptene on A2780 ovarian cancer cells. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(2):1895\u2013903.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"7","key":"3815_CR30","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1158\/1535-7163.MCT-07-0107","volume":"6","author":"C-T Chiang","year":"2007","unstructured":"Chiang C-T, Way T-D, Lin J-K. Sensitizing HER2-overexpressing cancer cells to luteolin-induced apoptosis through suppressing p21WAF1\/CIP1 expression with rapamycin. Mol Cancer Ther. 2007;6(7):2127\u201338.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"3815_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10529-021-03200-3","volume":"44","author":"P Saxena","year":"2022","unstructured":"Saxena P, Selvaraj K, Khare SK, Chaudhary N. Superoxide dismutase as multipotent therapeutic antioxidant enzyme: role in human diseases. Biotechnol Lett. 2022;44(1):1\u201322.","journal-title":"Biotechnol Lett"},{"issue":"2","key":"3815_CR32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s10787-024-01596-8","volume":"33","author":"D Singh","year":"2025","unstructured":"Singh D, Shukla G. The multifaceted anticancer potential of luteolin: involvement of NF-\u03baB, AMPK\/mTOR, PI3K\/Akt, MAPK, and Wnt\/\u03b2-catenin pathways. Inflammopharmacology. 2025;33(2):505\u201325.","journal-title":"Inflammopharmacology"},{"issue":"1","key":"3815_CR33","doi-asserted-by":"publisher","first-page":"G66","DOI":"10.1152\/ajpgi.00248.2006","volume":"292","author":"DY Lim","year":"2007","unstructured":"Lim DY, Jeong Y, Tyner AL, Park JH. Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin. Am J Physiol Gastrointest Liver Physiol. 2007;292(1):G66-75.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"3815_CR34","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1021\/ja3105208","volume":"135","author":"Y-P Chen","year":"2013","unstructured":"Chen Y-P, Chen C-T, Hung Y, Chou C-M, Liu T-P, Liang M-R, et al. A new strategy for intracellular delivery of enzyme using mesoporous silica nanoparticles: superoxide dismutase. J Am Chem Soc. 2013;135(4):1516\u201323.","journal-title":"J Am Chem Soc"},{"issue":"7","key":"3815_CR35","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1039\/C4BM00369A","volume":"3","author":"Z Yang","year":"2015","unstructured":"Yang Z, Gao D, Cao Z, Zhang C, Cheng D, Liu J, et al. Drug and gene co-delivery systems for cancer treatment. Biomater Sci. 2015;3(7):1035\u201349.","journal-title":"Biomater Sci"},{"key":"3815_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113891","volume":"176","author":"X Xu","year":"2021","unstructured":"Xu X, Liu C, Wang Y, Koivisto O, Zhou J, Shu Y, et al. Nanotechnology-based delivery of CRISPR\/Cas9 for cancer treatment. Adv Drug Deliv Rev. 2021;176:113891.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"3815_CR37","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1039\/D0TB02168G","volume":"9","author":"BG Carvalho","year":"2021","unstructured":"Carvalho BG, Vit FF, Carvalho HF, Han SW, de la Torre LG. Recent advances in co-delivery nanosystems for synergistic action in cancer treatment. J Mater Chem B. 2021;9(5):1208\u201337.","journal-title":"J Mater Chem B"},{"key":"3815_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102535","volume":"63","author":"H Tonbul","year":"2021","unstructured":"Tonbul H, Sahin A, Tavukcuoglu E, Ultav G, Akbas S, Aktas Y, et al. Folic acid decoration of mesoporous silica nanoparticles to increase cellular uptake and cytotoxic activity of doxorubicin in human breast cancer cells. J Drug Deliv Sci Technol. 2021;63:102535.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"21","key":"3815_CR39","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.3390\/cancers14215373","volume":"14","author":"H Singh Tuli","year":"2022","unstructured":"Singh Tuli H, Rath P, Chauhan A, Sak K, Aggarwal D, Choudhary R, et al. Luteolin, a potent anticancer compound: from chemistry to cellular interactions and synergetic perspectives. Cancers. 2022;14(21):5373.","journal-title":"Cancers"},{"issue":"4","key":"3815_CR40","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1007\/s11051-014-2347-9","volume":"16","author":"H Dang","year":"2014","unstructured":"Dang H, Meng MHW, Zhao H, Iqbal J, Dai R, Deng Y, et al. Luteolin-loaded solid lipid nanoparticles synthesis, characterization, & improvement of bioavailability, pharmacokinetics in vitro and vivo studies. J Nanopart Res. 2014;16(4):2347.","journal-title":"J Nanopart Res"},{"issue":"48","key":"3815_CR41","doi-asserted-by":"publisher","first-page":"8608","DOI":"10.1039\/C4TB01374C","volume":"2","author":"C Yang","year":"2014","unstructured":"Yang C, Gao S, Kjems J. Folic acid conjugated chitosan for targeted delivery of siRNA to activated macrophages in vitro and in vivo. J Mater Chem B. 2014;2(48):8608\u201315.","journal-title":"J Mater Chem B"},{"issue":"6","key":"3815_CR42","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1134\/S0006350916060221","volume":"61","author":"AM Popov","year":"2016","unstructured":"Popov AM, Osipov AN, Korepanova EA, Krivoshapko ON, Artyukov AA, Klimovich AA. A study of the antioxidant and membranotropic activities of Luteolin using different model systems. Biophysics. 2016;61(6):843\u201350.","journal-title":"Biophysics"},{"issue":"1","key":"3815_CR43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2217\/nnm.11.166","volume":"7","author":"JM Rosenholm","year":"2012","unstructured":"Rosenholm JM, Mamaeva V, Sahlgren C, Lind\u00e9n M. Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage. Nanomed (Lond). 2012;7(1):111\u201320.","journal-title":"Nanomed (Lond)"},{"issue":"51","key":"3815_CR44","doi-asserted-by":"publisher","first-page":"48975","DOI":"10.1021\/acsomega.3c06562","volume":"8","author":"J Zhang","year":"2023","unstructured":"Zhang J, Shang J, Tang X, Xu X. Tfr aptamer-functionalized MSNs for enhancing targeted cellular uptake and therapy of cancer cells. ACS Omega. 2023;8(51):48975\u201383.","journal-title":"ACS Omega"},{"issue":"41","key":"3815_CR45","doi-asserted-by":"publisher","first-page":"26466","DOI":"10.18632\/oncotarget.25470","volume":"9","author":"K AbouAitah","year":"2018","unstructured":"AbouAitah K, Swiderska-Sroda A, Farghali AA, Wojnarowicz J, Stefanek A, Gierlotka S, et al. Folic acid-conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action. Oncotarget. 2018;9(41):26466\u201390.","journal-title":"Oncotarget"},{"issue":"1","key":"3815_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12645-024-00250-w","volume":"15","author":"Y Dutta Gupta","year":"2024","unstructured":"Dutta Gupta Y, Mackeyev Y, Krishnan S, Bhandary S. Mesoporous silica nanotechnology: promising advances in augmenting cancer theranostics. Cancer Nanotechnol. 2024;15(1):9.","journal-title":"Cancer Nanotechnol"},{"issue":"3","key":"3815_CR47","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1007\/s10971-020-05366-0","volume":"96","author":"S Islam","year":"2020","unstructured":"Islam S, Bakhtiar H, Alshoaibi A, Haider Z, Riaz S, Naseem S. Fast responsive thermally stable silica microspheres for sensing evaluation: sol\u2013gel approach. J Sol-Gel Sci Technol. 2020;96(3):614\u201326.","journal-title":"J Sol-Gel Sci Technol"},{"key":"3815_CR48","first-page":"552","volume":"96","author":"S Feng","year":"2019","unstructured":"Feng S, Zhang H, Xu S, Zhi C, Nakanishi H, Gao X-D. Folate-conjugated, mesoporous silica functionalized boron nitride nanospheres for targeted delivery of doxorubicin. Materials Science and Engineering: C. 2019;96:552\u201360.","journal-title":"Materials Science and Engineering: C"},{"issue":"4","key":"3815_CR49","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3390\/sci6040068","volume":"6","author":"MRF Mod Razif","year":"2024","unstructured":"Mod Razif MRF, Chan SY, Chew Y-L, Hassan M, Ahmad Hisham S, Abdul Rahman S, et al. Recent developments in luteolin-loaded nanoformulations for enhanced anti-carcinogenic activities: insights from in vitro and in vivo studies. Sci. 2024;6(4):68.","journal-title":"Sci"},{"issue":"6","key":"3815_CR50","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1007\/s00405-014-2903-z","volume":"271","author":"H Zhang","year":"2014","unstructured":"Zhang H, Li X, Zhang Y, Luan X. Luteolin induces apoptosis by activating Fas signaling pathway at the receptor level in laryngeal squamous cell line Hep-2 cells. Eur Arch Otorhinolaryngol. 2014;271(6):1653\u20139.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"3815_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s42452-024-06322-1","volume":"7","author":"AK Chettupalli","year":"2025","unstructured":"Chettupalli AK, Bukke SPN, Rahaman SA, Unnisa A, Adepu M, Kavitha M, et al. Ritonavir loaded solid lipid nanoparticles for oral drug delivery and bioavailability enhancement. Discover Appl Sci. 2025;7(1):58.","journal-title":"Discover Appl Sci"},{"key":"3815_CR52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.actbio.2021.05.019","volume":"129","author":"H Li","year":"2021","unstructured":"Li H, Wang Y, Tang Q, Yin D, Tang C, He E, et al. The protein corona and its effects on nanoparticle-based drug delivery systems. Acta Biomater. 2021;129:57\u201372.","journal-title":"Acta Biomater"},{"issue":"1","key":"3815_CR53","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s12935-022-02808-3","volume":"22","author":"P Prasher","year":"2022","unstructured":"Prasher P, Sharma M, Singh SK, Gulati M, Chellappan DK, Zacconi F, et al. Luteolin: a flavonoid with a multifaceted anticancer potential. Cancer Cell Int. 2022;22(1):386.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"3815_CR54","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1080\/16583655.2020.1812269","volume":"14","author":"MJ Ansari","year":"2020","unstructured":"Ansari MJ, Abdullah A, Abdulaziz AI, Mohammed AF, Bader A, Saad A, et al. Formulation, characterization, in vitro and in vivo evaluations of self-nanoemulsifying drug delivery system of Luteolin. J Taibah Univ Sci. 2020;14(1):1386\u2013401.","journal-title":"J Taibah Univ Sci"},{"issue":"8","key":"3815_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11080771","volume":"11","author":"J Wu","year":"2021","unstructured":"Wu J. The enhanced permeability and retention (EPR) effect: the significance of the concept and methods to enhance its application. J Pers Med. 2021;11(8):771.","journal-title":"J Pers Med"},{"issue":"4","key":"3815_CR56","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1039\/C7SC04004K","volume":"9","author":"M Fern\u00e1ndez","year":"2018","unstructured":"Fern\u00e1ndez M, Javaid F, Chudasama V. Advances in targeting the folate receptor in the treatment\/imaging of cancers. Chem Sci. 2018;9(4):790\u2013810.","journal-title":"Chem Sci"},{"issue":"2","key":"3815_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021046","volume":"25","author":"T Gonzalez","year":"2024","unstructured":"Gonzalez T, Muminovic M, Nano O, Vulfovich M. Folate receptor alpha\u2014a novel approach to cancer therapy. Int J Mol Sci. 2024;25(2):1046.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"3815_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076349","volume":"24","author":"K Djayanti","year":"2023","unstructured":"Djayanti K, Maharjan P, Cho KH, Jeong S, Kim MS, Shin MC, et al. Mesoporous silica nanoparticles as a potential nanoplatform: therapeutic applications and considerations. Int J Mol Sci. 2023;24(7):6349.","journal-title":"Int J Mol Sci"},{"key":"3815_CR59","doi-asserted-by":"publisher","first-page":"1008101","DOI":"10.37349\/eds.2025.1008101","volume":"3","author":"MG Gorobets","year":"2025","unstructured":"Gorobets MG, Toroptseva AV, Abdullina MI, Pokrovsky VS, Khachatryan DS, Bychkova AV. Folic acid conjugated with serum albumin for nano- and submicron delivery systems for applications in therapy and diagnostics. Explor Drug Sci. 2025;3:1008101.","journal-title":"Explor Drug Sci"},{"issue":"1","key":"3815_CR60","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/s12885-025-13831-8","volume":"25","author":"Z Lai","year":"2025","unstructured":"Lai Z, Pang Y, Zhou Y, Chen L, Zheng K, Yuan S, et al. Luteolin as an adjuvant effectively enhanced the efficacy of adoptive tumor-specific CTLs therapy. BMC Cancer. 2025;25(1):411.","journal-title":"BMC Cancer"},{"issue":"1","key":"3815_CR61","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11033-024-10178-4","volume":"52","author":"IE Eryilmaz","year":"2024","unstructured":"Eryilmaz IE, Colakoglu Bergel C, Arioz B, Huriyet N, Cecener G, Egeli U. Luteolin induces oxidative stress and apoptosis via dysregulating the cytoprotective Nrf2-Keap1-Cul3 redox signaling in metastatic castration-resistant prostate cancer cells. Mol Biol Rep. 2024;52(1):65.","journal-title":"Mol Biol Rep"},{"issue":"7","key":"3815_CR62","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.3390\/biomedicines11072080","volume":"11","author":"MAI Ibrahim","year":"2023","unstructured":"Ibrahim MAI, Othman R, Chee CF, Ahmad Fisol F. Evaluation of Folate-functionalized nanoparticle drug delivery systems\u2014effectiveness and concerns. Biomedicines. 2023;11(7):2080.","journal-title":"Biomedicines"},{"issue":"3","key":"3815_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/jfb15030074","volume":"15","author":"A Almomen","year":"2024","unstructured":"Almomen A, Alhowyan A. A comprehensive study on Folate-Targeted mesoporous silica nanoparticles loaded with 5-Fluorouracil for the enhanced treatment of gynecological cancers. J Funct Biomater. 2024;15(3):74.","journal-title":"J Funct Biomater"},{"issue":"6","key":"3815_CR64","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0031-9422(00)00235-1","volume":"55","author":"JB Harborne","year":"2000","unstructured":"Harborne JB, Williams CA. Advances in flavonoid research since 1992. Phytochemistry. 2000;55(6):481\u2013504.","journal-title":"Phytochemistry"},{"key":"3815_CR65","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jep.2018.05.019","volume":"225","author":"N Aziz","year":"2018","unstructured":"Aziz N, Kim M-Y, Cho JY. Anti-inflammatory effects of luteolin: a review of in vitro, in vivo, and in silico studies. J Ethnopharmacol. 2018;225:342\u201358.","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"3815_CR66","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.3390\/molecules13102628","volume":"13","author":"G Seelinger","year":"2008","unstructured":"Seelinger G, Merfort I, W\u00f6lfle U, Schempp CM. Anti-carcinogenic effects of the flavonoid luteolin. Molecules. 2008;13(10):2628\u201351.","journal-title":"Molecules"},{"issue":"9","key":"3815_CR67","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1158\/0008-5472.CAN-05-4062","volume":"66","author":"K Selvendiran","year":"2006","unstructured":"Selvendiran K, Koga H, Ueno T, Yoshida T, Maeyama M, Torimura T, et al. Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids. Cancer Res. 2006;66(9):4826\u201334.","journal-title":"Cancer Res"},{"issue":"3","key":"3815_CR68","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3390\/vaccines11030554","volume":"11","author":"M \u00c7etinkaya","year":"2023","unstructured":"\u00c7etinkaya M, Baran Y. Therapeutic potential of luteolin on cancer. Vaccines. 2023;11(3):554.","journal-title":"Vaccines"},{"issue":"11","key":"3815_CR69","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1177\/0960327114522502","volume":"33","author":"A Pandurangan","year":"2014","unstructured":"Pandurangan A, Dharmalingam P, Sadagopan S, Ganapasam S. Luteolin inhibits matrix metalloproteinase 9 and 2 in azoxymethane-induced colon carcinogenesis. Hum Exp Toxicol. 2014;33(11):1176\u201385.","journal-title":"Hum Exp Toxicol"},{"key":"3815_CR70","doi-asserted-by":"publisher","DOI":"10.1615\/JEnvironPatholToxicolOncol.2013007522","author":"AK Pandurangan","year":"2013","unstructured":"Pandurangan AK, Dharmalingam P, Sadagopan SKA, Ramar M, Munusamy A. Luteolin induces growth arrest in colon cancer cells through involvement of Wnt\/\u03b2-catenin\/GSK-3\u03b2 signaling. J Environ Pathol Toxicol Oncol. 2013. https:\/\/doi.org\/10.1615\/JEnvironPatholToxicolOncol.2013007522.","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"3815_CR71","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.fct.2013.02.022","volume":"56","author":"S-H Park","year":"2013","unstructured":"Park S-H, Park HS, Lee JH, Chi GY, Kim G-Y, Moon S-K, et al. Induction of endoplasmic reticulum stress-mediated apoptosis and non-canonical autophagy by Luteolin in NCI-H460 lung carcinoma cells. Food Chem Toxicol. 2013;56:100\u20139.","journal-title":"Food Chem Toxicol"},{"issue":"12","key":"3815_CR72","doi-asserted-by":"publisher","first-page":"5560","DOI":"10.1111\/jcmm.16568","volume":"25","author":"M Zhang","year":"2021","unstructured":"Zhang M, Wang R, Tian J, Song M, Zhao R, Liu K, et al. Targeting LIMK1 with luteolin inhibits the growth of lung cancer in vitro and in vivo. J Cell Mol Med. 2021;25(12):5560\u201371.","journal-title":"J Cell Mol Med"},{"issue":"12","key":"3815_CR73","doi-asserted-by":"publisher","first-page":"e52279","DOI":"10.1371\/journal.pone.0052279","volume":"7","author":"P Pratheeshkumar","year":"2012","unstructured":"Pratheeshkumar P, Son Y-O, Budhraja A, Wang X, Ding S, Wang L, et al. Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. PLoS ONE. 2012;7(12):e52279.","journal-title":"PLoS ONE"},{"issue":"2","key":"3815_CR74","first-page":"142","volume":"93","author":"X Lu","year":"2013","unstructured":"Lu X, Li Y, Xiao X, Li X. Inhibitory effects of luteolin on human gastric carcinoma xenografts in nude mice and its mechanism. Zhonghua Yi Xue Za Zhi. 2013;93(2):142\u20136.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"1","key":"3815_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-015-0398-z","volume":"13","author":"J Lu","year":"2015","unstructured":"Lu J, Li G, He K, Jiang W, Xu C, Li Z, et al. Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer. J Transl Med. 2015;13(1):1\u201311.","journal-title":"J Transl Med"},{"key":"3815_CR76","doi-asserted-by":"publisher","first-page":"5315","DOI":"10.1007\/s11033-013-2632-1","volume":"40","author":"W-Y Cheng","year":"2013","unstructured":"Cheng W-Y, Chiao M-T, Liang Y-J, Yang Y-C, Shen C-C, Yang C-Y. Luteolin inhibits migration of human glioblastoma U-87 MG and T98G cells through downregulation of Cdc42 expression and PI3K\/AKT activity. Mol Biol Rep. 2013;40:5315\u201326.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"3815_CR77","first-page":"25","volume":"28","author":"J-T Hwang","year":"2011","unstructured":"Hwang J-T, Park OJ, Lee YK, Sung MJ, Hur HJ, Kim MS, et al. Anti-tumor effect of Luteolin is accompanied by AMP-activated protein kinase and nuclear factor-\u03baB modulation in HepG2 hepatocarcinoma cells. Int J Mol Med. 2011;28(1):25\u201331.","journal-title":"Int J Mol Med"},{"issue":"11","key":"3815_CR78","doi-asserted-by":"publisher","first-page":"4136","DOI":"10.1016\/j.fct.2012.08.025","volume":"50","author":"E-J Lee","year":"2012","unstructured":"Lee E-J, Oh S-Y, Sung M-K. Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells. Food Chem Toxicol. 2012;50(11):4136\u201343.","journal-title":"Food Chem Toxicol"},{"issue":"2","key":"3815_CR79","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1021\/jf062088r","volume":"55","author":"T Chen","year":"2007","unstructured":"Chen T, Li L-P, Lu X-Y, Jiang H-D, Zeng S. Absorption and excretion of luteolin and apigenin in rats after oral administration of chrysanthemum morifolium extract. J Agric Food Chem. 2007;55(2):273\u20137.","journal-title":"J Agric Food Chem"},{"key":"3815_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114078","volume":"157","author":"H Kaci","year":"2023","unstructured":"Kaci H, Bodn\u00e1rov\u00e1 S, Flisz\u00e1r-Ny\u00fal E, Lemli B, Pelantov\u00e1 H, Valentov\u00e1 K, et al. Interaction of luteolin, naringenin, and their sulfate and glucuronide conjugates with human serum albumin, cytochrome P450 (CYP2C9, CYP2C19, and CYP3A4) enzymes and organic anion transporting polypeptide (OATP1B1 and OATP2B1) transporters. Biomed Pharmacother. 2023;157:114078.","journal-title":"Biomed Pharmacother"},{"key":"3815_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.fbio.2023.102366","volume":"52","author":"SP Bangar","year":"2023","unstructured":"Bangar SP, Kajla P, Chaudhary V, Sharma N, Ozogul F. Luteolin. A flavone with myriads of bioactivities and food applications. Food Biosci. 2023;52:102366.","journal-title":"Food Biosci"},{"issue":"37","key":"3815_CR82","doi-asserted-by":"publisher","first-page":"61146","DOI":"10.18632\/oncotarget.18019","volume":"8","author":"S Zheng","year":"2017","unstructured":"Zheng S, Cheng Y, Teng Y, Liu X, Yu T, Wang Y, et al. Application of luteolin nanomicelles anti-glioma effect with improvement in vitro and in vivo. Oncotarget. 2017;8(37):61146.","journal-title":"Oncotarget"},{"issue":"13","key":"3815_CR83","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.7314\/APJCP.2014.15.13.5311","volume":"15","author":"M Sabzichi","year":"2014","unstructured":"Sabzichi M, Hamishehkar H, Ramezani F, Sharifi S, Tabasinezhad M, Pirouzpanah M, et al. Luteolin-loaded phytosomes sensitize human breast carcinoma MDA-MB 231 cells to doxorubicin by suppressing Nrf2 mediated signalling. Asian Pac J Cancer Prev. 2014;15(13):5311\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"11","key":"3815_CR84","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3390\/ph14111143","volume":"14","author":"MA Altamimi","year":"2021","unstructured":"Altamimi MA, Hussain A, AlRajhi M, Alshehri S, Imam SS, Qamar W. Luteolin-loaded elastic liposomes for transdermal delivery to control breast cancer: in vitro and ex vivo evaluations. Pharmaceuticals. 2021;14(11):1143.","journal-title":"Pharmaceuticals"},{"issue":"2","key":"3815_CR85","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4103\/jcrt.JCRT_438_18","volume":"16","author":"J Ding","year":"2020","unstructured":"Ding J, Li Q, He S, Xie J, Liang X, Wu T, et al. Luteolin-loading of Her-2-poly (lactic-co-glycolic acid) nanoparticles and proliferative inhibition of gastric cancer cells via targeted regulation of forkhead box protein O1. J Cancer Res Ther. 2020;16(2):263\u20138.","journal-title":"J Cancer Res Ther"},{"key":"3815_CR86","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.micromeso.2016.08.038","volume":"236","author":"AF Moreira","year":"2016","unstructured":"Moreira AF, Dias DR, Correia IJ. Stimuli-responsive mesoporous silica nanoparticles for cancer therapy: a review. Microporous Mesoporous Mater. 2016;236:141\u201357.","journal-title":"Microporous Mesoporous Mater"},{"issue":"1","key":"3815_CR87","doi-asserted-by":"publisher","first-page":"77","DOI":"10.53560\/PPASB(58-1)646","volume":"58","author":"A Hussain","year":"2021","unstructured":"Hussain A. Hydrophobic drug release studies from the core\/shell magnetic mesoporous silica nanoparticles and their anticancer application: drug release studies from magnetic mesoporous nanoparticles and their anticancer application. Proc Pakistan Acad Sciences: B Life Environ Sci. 2021;58(1):77\u201388.","journal-title":"Proc Pakistan Acad Sciences: B Life Environ Sci"},{"key":"3815_CR88","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1039\/c8pp00143j","volume":"17","author":"S Bayir","year":"2018","unstructured":"Bayir S, Barras A, Boukherroub R, Szunerits S, Raehm L, Richeter S, et al. Mesoporous silica nanoparticles in recent photodynamic therapy applications. Photochem Photobiol Sci. 2018;17:1651\u201374.","journal-title":"Photochem Photobiol Sci"},{"key":"3815_CR89","doi-asserted-by":"publisher","first-page":"119723","DOI":"10.1016\/j.biomaterials.2019.119723","volume":"232","author":"Y-J Ho","year":"2020","unstructured":"Ho Y-J, Wu C-H, Jin Q-f, Lin C-Y, Chiang P-H, Wu N, et al. Superhydrophobic drug-loaded mesoporous silica nanoparticles capped with \u03b2-cyclodextrin for ultrasound image-guided combined antivascular and chemo-sonodynamic therapy. Biomaterials. 2020;232:119723.","journal-title":"Biomaterials"},{"issue":"12","key":"3815_CR90","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1039\/c3nr00357d","volume":"5","author":"KT Mody","year":"2013","unstructured":"Mody KT, Popat A, Mahony D, Cavallaro AS, Yu C, Mitter N. Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery. Nanoscale. 2013;5(12):5167\u201379.","journal-title":"Nanoscale"},{"key":"3815_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.127060","author":"R Heidari","year":"2023","unstructured":"Heidari R, Assadollahi V, Khosravian P, Mirzaei SA, Elahian F. Engineered mesoporous silica nanoparticles, new insight nanoplatforms into effective cancer gene therapy. Int J Biol Macromol. 2023. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.127060.","journal-title":"Int J Biol Macromol"},{"issue":"12","key":"3815_CR92","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1039\/D2BM00181K","volume":"10","author":"JA Mills","year":"2022","unstructured":"Mills JA, Liu F, Jarrett TR, Fletcher NL, Thurecht KJ. Nanoparticle based medicines: approaches for evading and manipulating the mononuclear phagocyte system and potential for clinical translation. Biomaterials Sci. 2022;10(12):3029\u201353.","journal-title":"Biomaterials Sci"},{"issue":"3","key":"3815_CR93","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s13346-019-00631-4","volume":"9","author":"Z Hussain","year":"2019","unstructured":"Hussain Z, Khan S, Imran M, Sohail M, Shah SWA, de Matas M. PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution. Drug Deliv Transl Res. 2019;9(3):721\u201334.","journal-title":"Drug Deliv Transl Res"},{"issue":"24","key":"3815_CR94","doi-asserted-by":"publisher","first-page":"10748","DOI":"10.1039\/D1NR02065J","volume":"13","author":"L Shi","year":"2021","unstructured":"Shi L, Zhang J, Zhao M, Tang S, Cheng X, Zhang W, et al. Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery. Nanoscale. 2021;13(24):10748\u201364.","journal-title":"Nanoscale"},{"issue":"4","key":"3815_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043188","volume":"24","author":"N Ku\u010duk","year":"2023","unstructured":"Ku\u010duk N, Primo\u017ei\u010d M, Knez \u017d, Leitgeb M. Sustainable biodegradable biopolymer-based nanoparticles for healthcare applications. Int J Mol Sci. 2023;24(4):3188.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"3815_CR96","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1039\/c3cs35405a","volume":"42","author":"SH Wu","year":"2013","unstructured":"Wu SH, Mou CY, Lin HP. Synthesis of mesoporous silica nanoparticles. Chem Soc Rev. 2013;42(9):3862\u201375.","journal-title":"Chem Soc Rev"},{"issue":"12","key":"3815_CR97","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1246\/bcsj.20200136","volume":"93","author":"B Singh","year":"2020","unstructured":"Singh B, Na J, Konarova M, Wakihara T, Yamauchi Y, Salomon C, et al. Functional mesoporous silica nanomaterials for catalysis and environmental applications. Bull Chem Soc Jpn. 2020;93(12):1459\u201396.","journal-title":"Bull Chem Soc Jpn"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03815-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03815-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03815-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:03:10Z","timestamp":1761300190000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03815-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3815"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03815-2","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All institutional and national guidelines for the care and use of laboratory animals were followed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1960"}}